GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options and Proposed Secondary Placing

24 Sep 2021 15:00

RNS Number : 9520M
Fulham Shore PLC (The)
24 September 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 ("MAR"), WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

IN ADDITION, MARKET SOUNDINGS WERE TAKEN IN RESPECT OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

The Fulham Shore Plc

("Fulham Shore", the "Company" or "Group")

Exercise of Options and Proposed Secondary Placing

The Board of Fulham Shore (the "Board") announces that it has been informed by employees, including certain Directors, of their intention to exercise options over Ordinary Shares in the Company (the "Options"). These employees intend to subsequently sell the Ordinary Shares issued pursuant to the Option exercises at a price of 18 pence per share ("Placing Price") by way of an accelerated bookbuild. In addition, a further 9.5 million Ordinary Shares will be sold at the Placing Price by other shareholders of the Company.

Exercise of Options

In total, 17,187,829 Options over new ordinary shares of 1p each in the Company ("Ordinary Shares") will be exercised by employees including certain Directors. All the Options were either granted pursuant to the Company's EMI Share Option Plan or Unapproved Share Option Plan in 2014 or the Company Share Option Plan ("CSOP") in 2018.

Of these exercised Options, 13,804,987 options will be net-settled pursuant to the amendments to the Unapproved Share Option Plan announced by the Company on 22 February 2021 and will result in the issue of 9,991,457 new Ordinary Shares.

The Options to be exercised by certain Directors as follows:

Name

Option Scheme

No. of Options Exercised

Exercise Price (£)

 Net-settled Shares

to be Admitted

NAG Mankarious

Unapproved

1,647,256

0.06

1,192,213

DM Page

EMI

3,332,842

0.06

3,332,842

Unapproved

1,647,256

0.06

1,192,213

NJ Donaldson

Unapproved

4,980,098

0.06

3,604,381

NCW Wong

Unapproved

2,205,242

0.06

1,596,060

MA Chapman

Unapproved

3,325,135

0.06

2,406,590

TOTAL

 

17,137,829

 

13,324,299

 

Following the exercise of options detailed above, the Company will have a total of 32,332,577 options over new Ordinary Shares outstanding under share option schemes, equivalent to 5.1% of the enlarged issued share capital of the Company.

Placing

The employees, including certain Directors, have indicated their intention to sell a total of 13,374,299 Ordinary Shares that will be issued pursuant to the Option exercises as detailed above at the Placing Price. In addition, certain other shareholders including Jawaid Akhtar, Franco Manca Operations Director, a person disclosing managerial responsibilities ("PDMR"), intend to sell a minimum of 9.5 million shares at the Placing Price. In aggregate, a total of 22.88 million Ordinary Shares are available for purchase (the "Placing Shares") equating to approximately 3.69% of the current issued share capital of the Company.

The details of these intended Option exercises and sales and the impact on the Directors' interests in the share capital of the Company are as follows:

 

Current

Resultant

Name

Shareholding

% of ISC

Shareholding

% of Enlarged ISC (post Share option exercise)

NAG Mankarious

116,879,434

18.8%

116,879,434

18.5%

DM Page

83,515,120

13.5%

83,515,120

13.2%

NJ Donaldson

14,998,573

2.4%

14,998,573

2.4%

NCW Wong

12,388,449

2.0%

12,388,449

2.0%

MA Chapman

1,086,818

0.2%

1,086,818

0.2%

DAL Gunewardena

774,545

0.1%

774,545

0.1%

TOTAL

229,642,939

37.0%

229,642,939

36.2%

 

The Placing will have the benefit of increasing Fulham Shore's free float whilst allowing the Directors to remain closely aligned with the interests of other shareholders. Fulham Shore will not receive any proceeds from the Placing.

Singer Capital Markets Securities Limited ("Singer Capital Markets") is acting as sole bookrunner. The bookbuild will commence with immediate effect following this announcement. A further announcement detailing the results of the Placing will be made upon completion.

The Placing is subject to demand and prevailing market conditions. The final number of Placing Shares to be placed will be agreed at the close of the bookbuild process, and the results of the Placing will be announced as soon as practicable thereafter. The timings for the close of the bookbuild process and allocations are at the absolute discretion of Singer Capital Markets.

The proceeds of the Placing are payable in cash and will have varying settlement dates depending on the Ordinary Shares purchased. 12,747,769 Placing Shares will be settled on a T+5 basis and 10,135,564 Placing Shares will be settled on a T+12 basis.

 

For further information, please contact:

 

The Fulham Shore PLC

www.fulhamshore.com

David Page / Nick Wong

 

Via Hudson Sandler

Singer Capital Markets (Nominated Adviser & Broker)

Shaun Dobson / James Moat / Kailey Aliyar / Hannah Woodley

 

+44 (0) 20 7496 3000 

Hudson Sandler - Financial PR

Alex Brennan / Lucy Wollam

fulhamshore@hudsonsandler.com

Telephone: 020 7796 4133

 

 

 

 

Notes for editors

 

Information on The Fulham Shore PLC

 

Fulham Shore owns and operates "The Real Greek" ( www.therealgreek.com ) and "Franco Manca" ( www.francomanca.co.uk ) restaurants.

 

Fulham Shore was incorporated in March 2012. The Directors believed that there were attractive investment opportunities within the restaurant sector in the UK and that, given their collective experience in the restaurant sector, they could take advantage of the opportunities which existed.

 

The ordinary shares of the Company were admitted to trading on AIM in October 2014 in order to capitalise on such opportunities and to give the company employees, customers and public the ability to share in the enterprise.

 

The Real Greek

 

Since its foundation in London in 1999, The Real Greek group has grown steadily, now offering modern Greek cuisine in 20 restaurants across London and Southern England.

 

The Real Greek food centres on the delicious, healthy diet of the Eastern Mediterranean, staying true to the Greek ethos of food, family and friends. Dishes are created using premium ingredients sourced from Greece and Cyprus whenever possible, and developed by Tonia Buxton, the face of Greek food in the UK.

 

The Real Greek's menu and atmosphere retain the spirit of eating in Greece, encouraging diners to take their time eating amongst friends and family, be it a relaxed dinner, family get-together, or a fully catered party.

 

Franco Manca

 

Franco Manca opened its first restaurant in 2008 and now has 55 restaurants, primarily in London, but also with restaurants across the UK (e.g. Edinburgh, Glasgow, Manchester, Leeds, Cambridge, Bath, Oxford, Bristol and Exeter).

 

Franco Manca's pizza is made from slow-rising sourdough and is baked in an oven that produces high heat. The slow levitation and blast cooking process lock in the flour's natural aroma and moisture, giving a soft and easily digestible crust. Where possible, locally sourced and organic ingredients are used.

 

Franco Manca has received the following accolades:

 

Winner of the Casual Dining Best Family Dining Experience Award 2020

Winner of the R200 Best Value Restaurant Operator- Over 20 Sites Award 2019 and 2017

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBXGDCUUDDGBS
Date   Source Headline
10th Jan 20087:01 amRNSProposed Board Changes
20th Dec 20075:35 pmRNSResult of AGM
26th Nov 20077:01 amRNSFinal Results
15th Nov 20077:01 amRNSNotice of Results/Trdg Update
6th Nov 20077:01 amRNSOpening of new US office
11th Oct 20077:01 amRNSContract Win
7th Sep 20077:01 amRNSRe Alliance
3rd Sep 20074:13 pmRNSDirector/PDMR Shareholding
20th Aug 20074:09 pmRNSDirector/PDMR Shareholding
17th Aug 20074:37 pmRNSAIM Rule 26
15th Aug 20077:01 amRNSTrading Update
17th May 20077:01 amRNSInterim Results
18th Apr 20074:46 pmRNSDirector/PDMR Shareholding
12th Apr 20071:40 pmRNSEGM Statement
19th Mar 200711:28 amRNSPlacing and Acquisition
21st Feb 20077:00 amRNSCompletion of Earn Out
21st Dec 20069:29 amRNSTotal Voting Rights
18th Dec 200612:52 pmRNSResult of AGM
15th Nov 20062:06 pmRNSDirector/PDMR Shareholding
9th Nov 20067:01 amRNSFinal Results
2nd Aug 20067:00 amRNSDirector/PDMR Shareholding
12th May 20067:01 amRNSEdinburgh Office Opens
9th May 20067:01 amRNSInterim Results
12th Apr 200610:30 amRNSContract with Celtic Pharma
5th Apr 20067:01 amRNSNanoCarrier Partnership
7th Mar 20067:01 amRNSBoard Appointment
9th Feb 20067:01 amRNSAcquisition of Quadramed Ltd
19th Dec 200512:09 pmRNSAGM Statement
14th Nov 200512:18 pmRNSDirector/PDMR Shareholding
9th Nov 20057:00 amRNSPreliminary Results
14th Sep 20057:02 amRNSTrading Update
18th May 20057:01 amRNSSyngenta Biopharma Agreement
18th May 20057:00 amRNSInterim Results
5th May 200512:20 pmRNSNotice of Interim Results
1st Mar 20057:03 amRNSPresent at Networking Evening
25th Jan 20057:00 amRNSPresentation with Addex
6th Jan 20057:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.